Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) (PLEO-CMT) [Completed] February 27, 2020https://clinicaltrials.gov/ct2/show/NCT02579759 https://clinicaltrials.gov/ct2/show/NCT02579759?recrs=abdef&type=Intr&cond=Charcot-Marie-Tooth&rank=10 >>> completed
Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A (PLEO-CMT-FU) September 19, 2019https://clinicaltrials.gov/ct2/show/NCT03023540